The CG-100 Intraluminal bypass device is being evaluated as a treatment to determine whether it can reduce the need for a diverting stoma and its related complications
If you are a rectal cancer patient between the ages of 22 and 65 and need to undergo colorectal surgery, you may qualify for our research study
A clinical study is underway across the U.S. for people undergoing colorectal surgery
See if the CG-100 procedure is right for you
The CG-100 Intraluminal bypass device
A temporary protective bypass device which is being evaluated as a treatment to determine whether it can reduce the need for a diverting stoma and its related complications.
The CG-100 device is designed to avoid contact of the anastomotic site with fecal material during its critical healing period. The study will evaluate whether it can reduce the life-threatening symptoms related to clinical anastomotic leaks.
We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Privacy Policy.
To agree to our use of cookies click Accept.